This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1975 Sep-Oct;59(5):895-900.

Synergistic interaction of anticancer agents: a cellular perspective

F Valeriote, H s Lin

PMID: 1203896

Synergistic interaction of anticancer agents: a cellular perspective

F Valeriote et al. Cancer Chemother Rep. 1975 Sep-Oct.

. 1975 Sep-Oct;59(5):895-900.

Authors

F Valeriote, H s Lin

PMID: 1203896

No abstract available

PubMed Disclaimer

Similar articles

The use of cell kinetics in the development of drug combinations.
Valeriote FA. Valeriote FA. Pharmacol Ther. 1979;4(1):1-33. doi: 10.1016/0163-7258(79)90013-5. Pharmacol Ther. 1979. PMID: 461499 No abstract available.
Biochemical rationales for the selection of combinations of chemotherapeutic agents.
Bono VH Jr. Bono VH Jr. Cancer Chemother Rep 2. 1974 Mar;4(1):131-6. Cancer Chemother Rep 2. 1974. PMID: 4826492 No abstract available.
[Current status of anticancer chemotherapy. Progress in concept, methods and means].
Chauvergne J. Chauvergne J. Rev Laryngol Otol Rhinol (Bord). 1977 May-Jun;98(5-6):271-89. Rev Laryngol Otol Rhinol (Bord). 1977. PMID: 897407 French. No abstract available.
Sensitivity of normal and neoplastic cells to chemotherapeutic agents in vitro.
Dow LW. Dow LW. Adv Intern Med. 1980;25:427-52. Adv Intern Med. 1980. PMID: 6987848 Review. No abstract available.
Computer models of anticancer drug interaction.
Jackson RC, Harrap KR. Jackson RC, et al. Pharmacol Ther. 1979;4(2):245-80. doi: 10.1016/0163-7258(79)90138-4. Pharmacol Ther. 1979. PMID: 386382 Review. No abstract available.

See all similar articles

Cited by

Cytotoxicity of combinations of prostaglandin D2 (PGD2) and antitumor drugs for B16 melanoma cells in culture.
Bhuyan BK, Badiner GJ, Adams EG, Chase R. Bhuyan BK, et al. Invest New Drugs. 1986;4(4):315-23. doi: 10.1007/BF00173504. Invest New Drugs. 1986. PMID: 3473056
Inhibition of human cytomegalovirus by combined acyclovir and vidarabine.
Spector SA, Kelley E. Spector SA, et al. Antimicrob Agents Chemother. 1985 Apr;27(4):600-4. doi: 10.1128/AAC.27.4.600. Antimicrob Agents Chemother. 1985. PMID: 2988432 Free PMC article.
The combination of the antitumoural pyridyl cyanoguanidine CHS 828 and etoposide in vitro--from cytotoxic synergy to complete inhibition of apoptosis.
Martinsson P, Ekelund S, Nygren P, Larsson R. Martinsson P, et al. Br J Pharmacol. 2002 Oct;137(4):568-73. doi: 10.1038/sj.bjp.0704888. Br J Pharmacol. 2002. PMID: 12359640 Free PMC article.
In-vitro effects of taurolidine alone and in combination with mitoxantrone and/or piroxicam on canine transitional cell carcinoma.
Byer B, Schlein LJ, Rose B, Séguin B. Byer B, et al. Can J Vet Res. 2020 Apr;84(2):115-123. Can J Vet Res. 2020. PMID: 32255906 Free PMC article.
Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.
Alberts DS, Salmon SE, Chen HS, Moon TE, Young L, Surwit EA. Alberts DS, et al. Cancer Chemother Pharmacol. 1981;6(3):253-64. doi: 10.1007/BF00256978. Cancer Chemother Pharmacol. 1981. PMID: 7318146

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database